Top cited articles

To celebrate another year of high quality, cutting edge content published in RMD Open, we have shortlisted the most cited papers of the past 2 years.

2020

2019

Serious infection risk in rheumatoid arthritis compared with non-inflammatory rheumatic and musculoskeletal diseases: a US national cohort study
FEB 2019 10.1136/rmdopen-2019-000935

Polymyalgia rheumatica-like syndrome from checkpoint inhibitor therapy: case series and systematic review of the literature
FEB 2019 10.1136/rmdopen-2019-000906

Era of biosimilars in rheumatology: reshaping the healthcare environment
FEB 2019 10.1136/rmdopen-2019-000900

Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations
JUNE 2019 10.1136/rmdopen-2019-001035

Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults
FEB 2019 10.1136/rmdopen-2019-000924

Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD
JUNE 2019 10.1136/rmdopen-2019-001041

Window of opportunity in rheumatoid arthritis – definitions and supporting evidence: from old to new perspectives
FEB 2019 10.1136/rmdopen-2018-000870

Effect of tofacitinib on patient-reported outcomes in patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors in the phase III, randomised controlled trial: OPAL Beyond
FEB 2019 10.1136/rmdopen-2018-000808

Management of Takayasu arteritis: a systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis
JUNE 2019 10.1136/rmdopen-2019-001020

EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases
JUNE 2019 10.1136/rmdopen-2019-001014